 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Boston Heart Diagnostics Launches Statin Induced Myopathy Genotype Test
May 30, 2012
Boston Heart Diagnostics Launches Statin Induced Myopathy Genotype Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Vanderbilt to Begin Genetic Testing to Predict Risk of Severe Muscle Toxicity with Simvastatin
October 19, 2011 / Pharmacogenomics Reporter - Celera Will Add to Quest's MDx Capabilities; But Reimbursement Questions Cloud Revenue Contribution
March 23, 2011 / Pharmacogenomics Reporter - Berkeley HeartLab Wins CAP Accreditation
March 4, 2010 / GenomeWeb Daily News - Berkeley HeartLab Inks Heart Dx Pact with Geisinger
October 29, 2009 / GenomeWeb Daily News - Celera and Medco Partner on Statin Drug PGx
September 22, 2009 / GenomeWeb Daily News